Clinician JUdgment Versus Risk Score to Predict Stroke outComes: The JURASSIC Clinical Trial
NCT01657279 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 111
Last updated 2012-10-30
Summary
Background: Several risk score models are now available to assist clinicians estimate outcomes after an acute ischemic stroke. Limited information is available on the predictive value of these scores compared to real outcomes and clinical judgment.
Objectives: To compare clinician judgment with the use of a validated stroke risk score (iScore) and patients' outcomes.
Conditions
- Stroke
- Ischemic Stroke
- Cerebrovascular Disease
Interventions
- OTHER
-
Clinical scenarios
Clinicians will be randomized to a sequence of 5 clinical scenarios with a variable range of expected outcome \[i.e. from low (\<10%) to high (\>50%) expected risk death at 30 days\].
Sponsors & Collaborators
-
Heart and Stroke Foundation of Ontario
collaborator OTHER -
Unity Health Toronto
lead OTHER
Principal Investigators
-
Gustavo Saposnik, MD MSc FRCPC · Unity Health Toronto
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2012-08-31
- Completion
- 2012-08-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
PG2 Injection 500 mg in Acute Stroke Study (Pass)
NCT01603667 ·Status: COMPLETED ·Phase: PHASE2
-
IMPROVE Stroke Care- Developing and Optimizing Regional Systems of Stroke Care
NCT04242784 ·Status: COMPLETED
-
Preventing Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack
NCT00931788 ·Status: COMPLETED ·Phase: PHASE4
-
REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)
NCT03861494 ·Status: COMPLETED ·Phase: NA
-
Personalized Antiplatelet Secondary Stroke PRevenTion
NCT03979781 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Thrombosis and Patients with Prior Ischemic Stroke Within 3 Months
NCT06841978 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy Study of Combined Treatment With Uric Acid and rtPA in Acute Ischemic Stroke
NCT00860366 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Clinical Trial to Assess the Acute Safety and Functional Outcome and Recovery After STROKE: The FIRST Trial
NCT01092819 ·Status: COMPLETED
-
Mild and Rapidly Improving Stroke Study
NCT02072681 ·Status: COMPLETED
-
Secondary Prevention of Stroke Through Non-drug Therapeutic Weight Reduction
NCT01721538 ·Status: UNKNOWN ·Phase: NA
-
Effect of Zoledronic Acid on Prevention of Bone Loss in Acute Phase First-ever Stroke Patients
NCT04652128 ·Status: UNKNOWN ·Phase: NA
-
Effect of Human Urinary Kallidinogenase on Inflammatory Factors in Acute Ischemic Stroke (KIF-AIS)
NCT06696703 ·Status: RECRUITING ·Phase: NA
-
Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
NCT03062397 ·Status: UNKNOWN ·Phase: PHASE2
-
Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke (Japan Alteplase Clinical Trial Ⅱ:J-ACT Ⅱ)
NCT00412867 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy Study in Acute Ischaemic Stroke
NCT00144014 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Thrombolytic Therapy for Acute Ischemic Stroke Patients with Low NIHSS and Non-disabling Deficits
NCT06115070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke
NCT03618290 ·Status: COMPLETED
-
The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers
NCT01983358 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of IL-33 in Patients With the Acute Ischemic Stroke
NCT03948802 ·Status: COMPLETED
-
StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial
NCT06785727 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Reduction of Edema With a Specialized Cocktail for Ultra-early Management in Ischemic Stroke
NCT06863571 ·Status: RECRUITING ·Phase: PHASE3
-
MLC1501 Study Assessing Efficacy in STROke Recovery
NCT05046106 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Effects of Urinary Kallidinogenase in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism
NCT04020666 ·Status: COMPLETED
-
Transitional Care Program to Improve Risk Factors in Stroke Survivors
NCT06657235 ·Status: RECRUITING ·Phase: NA
-
Stroke Treatment With Acute Reperfusion and Simvastatin
NCT01073007 ·Status: COMPLETED ·Phase: PHASE4